"We are exploring the option of US enrollment in the BETonMACE trial as well as the option of relying on existing BETonMACE data to file a US New Drug Application (NDA)."
Hmmmmm. All that work to get FDA approval for inclusion of US patients in BETonMACE and now this? Interesting.....